Healthcare Professionals
About AGGRASTAT
®
Indications and Usage
Dosing and Administration
Efficacy
Safety and Tolerability Profile
ACS Guidelines
Key AGGRASTAT Studies
PRISM
PRISM-PLUS
TACTICS
A to Z Trial
ACUTE II
TIMI Criteria
High-Risk Patients
ST-Segment Changes
Renal Insufficiency
Diabetes
Elevated Troponin-I
Resources
Prescribing Information
Slide Sets
Useful Links
Email Me Updates
Request More Information
Email Me Updates
I would like to be notified when there is new information about AGGRASTAT
®
.
Full Name:
*
Email Address:
*
Would you like to subscribe or unsubscribe?
*
Subscribe
Unsubscribe
*
Indicates a required field
AGGRASTAT is a registered trademark of Merck & Co., Inc., Whitehouse Station, NJ, USA
